山西德元堂药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
82
NMPA:82
Drug Approvals
Olmesartan Medoxomil and Amlodipine Besylate Tablets
- Product Name
- 奥美沙坦酯氨氯地平片
- Approval Number
- 国药准字H20254275
- Approval Date
- May 27, 2025
NMPA
Olmesartan Medoxomil and Amlodipine Besylate Tablets
- Product Name
- 奥美沙坦酯氨氯地平片
- Approval Number
- 国药准字H20254276
- Approval Date
- May 27, 2025
NMPA
Diprophylline Injection
- Product Name
- 二羟丙茶碱注射液
- Approval Number
- 国药准字H20253573
- Approval Date
- Mar 11, 2025
NMPA
Acetylcysteine Solution for Inhalation
- Product Name
- 吸入用乙酰半胱氨酸溶液
- Approval Number
- 国药准字H20253503
- Approval Date
- Mar 4, 2025
NMPA
Telmisartan and Amlodipine Tablets（Ⅱ）
- Product Name
- 替米沙坦氨氯地平片(Ⅱ)
- Approval Number
- 国药准字H20253314
- Approval Date
- Jan 24, 2025
NMPA
Moxifloxacin Hydrochloride Tablets
- Product Name
- 盐酸莫西沙星片
- Approval Number
- 国药准字H20253145
- Approval Date
- Jan 14, 2025
NMPA
Lornoxicam for Injection
- Product Name
- 注射用氯诺昔康
- Approval Number
- 国药准字H20249829
- Approval Date
- Dec 25, 2024
NMPA
Urapidil Hydrochloride Injection
- Product Name
- 盐酸乌拉地尔注射液
- Approval Number
- 国药准字H20249706
- Approval Date
- Dec 6, 2024
NMPA
Urapidil Hydrochloride Injection
- Product Name
- 盐酸乌拉地尔注射液
- Approval Number
- 国药准字H20249705
- Approval Date
- Dec 6, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
Clinical Trials
No trials found
News
No news found